Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Molecules ; 28(6)2023 Mar 08.
Artículo en Inglés | MEDLINE | ID: mdl-36985444

RESUMEN

Metformin is a first-line drug for the clinical treatment of type 2 diabetes; however, it always leads to gastrointestinal tolerance, low bioavailability, short half-life, etc. Liposome acts as an excellent delivery system that could reduce drug side effects and promote bioavailability. Hyodeoxycholic acid, a cholesterol-like structure, can regulate glucose homeostasis and reduce the blood glucose levels. As an anti-diabetic active ingredient, hyodeoxycholic acid modifies liposomes to make it overcome the disadvantages of metformin as well as enhance the hypoglycemic effect. By adapting the thin-film dispersion method, three types of liposomes with different proportions of hyodeoxycholic acid and metformin were prepared (HDCA:ME-(0.5:1)-Lips, HDCA:ME-(1:1)-Lips, and HDCA:ME-(2:1)-Lips). Further, the liposomes were characterized, and the anti-type 2 diabetes activity of liposomes was evaluated. The results from this study indicated that three types of liposomes exhibited different characteristics-Excessive hyodeoxycholic acid decreased encapsulation efficiency and drug loading. In the in vivo experiments, liposomes could reduce the fasting blood glucose levels, improve glucose tolerance, regulate oxidative stress markers and protect liver tissue in type 2 diabetic mice. These results indicated that HDCA:ME-(1:1)-Lips was the most effective among the three types of liposomes prepared and showed better effects than metformin. Hyodeoxycholic acid can enhance the hypoglycemic effect of metformin and play a suitable role as an excipient in the liposome.


Asunto(s)
Diabetes Mellitus Experimental , Diabetes Mellitus Tipo 2 , Metformina , Ratones , Animales , Liposomas/química , Metformina/farmacología , Metformina/uso terapéutico , Diabetes Mellitus Experimental/tratamiento farmacológico , Glucemia , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Sistemas de Liberación de Medicamentos , Hipoglucemiantes/farmacología , Hipoglucemiantes/uso terapéutico
2.
Int J Biol Macromol ; 194: 945-953, 2022 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-34838858

RESUMEN

Cotton fibers mainly consist of cellulose biological macromolecule, and its exceedingly flammable nature has severely restricted its application in the fields requiring flame retardancy. To endow cotton fabric with excellent flame retardancy and superior durability, a high-efficiency durable flame retardant (THPO-P) with ammonium phosphate ester and phosphine oxide groups was synthesized and chemically bonded to cotton fabric through padding-baking method. THPO-P showed high flame-retardant efficiency, and the add-on of 5.9% was sufficient to prepare cotton fabric with self-extinguished feature. With the add-on of 19.9%, treated fabric possessed excellent fire safety and durability. The total heat release and peak heat release rate values reduced by 77.1% and 91.8% in contrast to pristine fabric, respectively. Its LOI value still reached up to 33.4% even after 50 laundering cycles, which was far beyond the flame-retardant standard. THPO-P played flame-retardant role by restraining the release of flammable volatiles, liberating nonflammable gases and promoting the char formation during combustion. The flame-retardant treatment deteriorated the tensile strength, whiteness and softness of cotton fabric.


Asunto(s)
Celulosa/química , Fibra de Algodón/análisis , Ésteres/química , Retardadores de Llama/análisis , Fosfatos/química , Fosfinas/química , Textiles/análisis , Técnicas de Química Sintética , Retardadores de Llama/síntesis química , Estructura Molecular , Óxidos , Análisis Espectral , Termogravimetría
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA